Patient-Reported Symptom Burden Among Thyroid Cancer Survivors: Retrospective Cohort Study
JCO Clinical Cancer Informatics · 2026-07 · 10 (3)
DOI: 10.1200/cci-26-00041 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift JCO Clinical Cancer Informatics, 2026-07. Verfasst von Jason B Liu und 29 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Patient Reported Outcome Measures, Cancer Survivors. Die Arbeit nennt 31 Literaturangaben.
Abstract (Originalsprache)
PURPOSE Survivorship care models that extend beyond recurrence surveillance to ones that also address treatment-related symptoms are needed. Using data obtained in routine clinical care, we aimed to examine patient-reported symptom burden among adult thyroid cancer survivors. METHODS Between September 2019 and September 2022, adults were electronically administered the MDASI-Thy, a patient-reported outcome measure that measures symptom severity and interference, within 7 days before their visit at a dedicated thyroid cancer survivorship clinic. The MDASI-Thy generates (1) core symptom severity, (2) thyroid-specific symptom severity, and (3) symptom interference scores, where lower is better. High alert values (HAVs) were defined for four symptoms: Distress (Upset), Pain, Sad, and Shortness of Breath. Multivariable generalized linear models examined associations of patient, cancer, and treatment factors with scores and any HAV. RESULTS Among 1,557 thyroid cancer survivors, 864 (55.5%) responded. Respondents were a median of 5 years from diagnosis (IQR, 4-8) and predominantly female (79.1%), and most had papillary thyroid carcinoma (92.5%). Mean (standard deviation) scores were 1.20 (1.34) for core severity, 0.99 (1.26) for thyroid-specific severity, and 1.07 (1.80) for interference. Fatigue (11.5%) and Disturbed Sleep (11.3%) were the most common severe symptoms. HAVs occurred in 72 survivors (8.3%), of whom 54 (75%) had a documented plan addressing the HAV. Higher symptom burden was associated with female sex, Black race, greater comorbidity, active smoking, and total thyroidectomy. CONCLUSION Routine patient-reported symptom screening in thyroid cancer survivorship identified generally low symptom burden but meaningful variations, with a subset reporting severe symptoms, functional interference, and HAVs requiring action.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
- Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX.
- Patient-Reported Outcomes, Value, and Experience (PROVE) Center, Mass General Brigham, Boston, MA.
- Department of Surgery, Emory University School of Medicine, Atlanta, GA.
- Advanced Practice Providers Program-Survivorship, The University of Texas MD Anderson Cancer Center, Houston, TX.
- Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX.
ORCID-Profile: Jason B Liu, Thomas Szabo Yamashita, Loretta A Williams, Mark E Zafereo, Anastasios Maniakas, Jennifer R Wang, Naifa L Busaidy, Maria E Cabanillas, Luz E Castellanos, Mimi I Hu, Anita K Ying, Steven I Sherman, Steven G Waguespack, Steven P Weitzman, Nancy D Perrier, Eileen H Shinn, Michael E Roth, Elizabeth G Grubbs, Sarah B Fisher
Zitieren
APA
Liu, J. B., Yamashita, T. S., Rollins, J. L., Lee-Kim, S. H., Avula, K. C., Chacko, R., Peek, A., Williams, L. A., Zafereo, M. E., Maniakas, A., Wang, J. R., Busaidy, N. L., Cabanillas, M. E., Castellanos, L. E., Chaudhri, A., Dadu, R., Hu, M. I., Vasquez, C. J., Ying, A. K., …, & Fisher, S. B. (2026). Patient-Reported Symptom Burden Among Thyroid Cancer Survivors: Retrospective Cohort Study. JCO Clinical Cancer Informatics, 10(3). https://doi.org/10.1200/cci-26-00041
Vancouver
Liu JB, Yamashita TS, Rollins JL, Lee-Kim SH, Avula KC, Chacko R, et al. Patient-Reported Symptom Burden Among Thyroid Cancer Survivors: Retrospective Cohort Study. JCO Clinical Cancer Informatics. 2026;10(3). doi:10.1200/cci-26-00041
BibTeX
@article{Liu2026,
author = {Liu, Jason B and Yamashita, Thomas Szabo and Rollins, Johnny L and Lee-Kim, Soo-Hyun and Avula, Khavya C and Chacko, Rachel and Peek, Angela and Williams, Loretta A and Zafereo, Mark E and Maniakas, Anastasios and Wang, Jennifer R and Busaidy, Naifa L and Cabanillas, Maria E and Castellanos, Luz E and Chaudhri, Aysha and Dadu, Ramona and Hu, Mimi I and Vasquez, Camilo Jimenez and Ying, Anita K and Varghese, Jeena M and Sherman, Steven I and Waguespack, Steven G and Weitzman, Steven P and Graham, Paul H and Perrier, Nancy D and Shinn, Eileen H and Roth, Michael E and Habra, Mouhammed Amir and Grubbs, Elizabeth G and Fisher, Sarah B},
title = {Patient-Reported Symptom Burden Among Thyroid Cancer Survivors: Retrospective Cohort Study},
journal = {JCO Clinical Cancer Informatics},
year = {2026},
volume = {10},
number = {3},
doi = {10.1200/cci-26-00041}
}
EUVIMED